Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Arteriosclerosis D001161 86 associated lipids
Body Weight D001835 333 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
pmid:
Edelstyn GA and MacRae KD "Early" and "late" breast cancer: a unified concept for treatment. 1976 Clin Radiol pmid:1000891
Schley G et al. [Oral contraceptives in prophylaxis of acute exacerbations of intermittent porphyria (author's transl)]. 1976 Dtsch. Med. Wochenschr. pmid:1001215
Jori A and Dolfini E Modifications of striatal dopamine levels by steroid contraceptive drugs in mice and rats. 1976 Neuroendocrinology pmid:1004687
Surrey ES Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group. 1999 Fertil. Steril. pmid:10065775
Graff-Iversen S et al. Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: results from a cross-sectional study in two Norwegian counties 1985-1988. 1998 J Clin Epidemiol pmid:10086825
Kimmerle R et al. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. 1999 Menopause pmid:10100178
Rundle FW Cervical teratoma. 1976 J Otolaryngol pmid:1011335
Beckman G et al. Naphthylamidase isoenzymes in serum during treatment with oral contraceptives. 1976 Int J Gynaecol Obstet pmid:10197
Loi CM et al. Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent. 1999 J Clin Pharmacol pmid:10197300
Franklin RD and Kutteh WH Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. 1999 J. Reprod. Immunol. pmid:10221733
Barditch-Crovo P et al. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. 1999 Clin. Pharmacol. Ther. pmid:10223781
Fender GR et al. Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. 1999 BMJ pmid:10231255
Soutoul JH et al. [Oral contraception by means of progestagen-only micropills taken continuously in the light of four recent trials (author's transl)]. 1976 Rev Fr Gynecol Obstet pmid:1023328
Hampton AL et al. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. 1999 Mol. Hum. Reprod. pmid:10321809
Elstein M et al. The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels. 1976 Br J Obstet Gynaecol pmid:1032819
Pérez-Medina T et al. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up. 1999 Gynecol. Oncol. pmid:10329050
Charkoudian N and Johnson JM Altered reflex control of cutaneous circulation by female sex steroids is independent of prostaglandins. 1999 Am. J. Physiol. pmid:10330248
Gruber DM et al. Endometrial cancer after combined hormone replacement therapy. 1999 Maturitas pmid:10340283
Scheffler MR et al. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics. 1999 Clin. Pharmacol. Ther. pmid:10340913
Stanczyk FZ et al. Effect of oral contraceptives containing 20 and 35 micrograms ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers. 1999 Contraception pmid:10342082
Campos MG et al. The androgenic effect of norethisterone and 5alpha-norethisterone on the contractile response of the rat vas deferens to methoxamine and serotonin. 1999 Life Sci. pmid:10350363
Johansson ED and Kral JG Oral contraceptives after intestinal bypass operations. 1976 JAMA pmid:1036586
Gerhards E et al. Studies of the kinetics and metabolism of 17 beta-heptanoyl-17 alpha-ethinyl-4-oestren-3-one-7-3H (norethisterone enanthate) in humans following intramuscular injection. 1976 Arzneimittelforschung pmid:1036962
Wahrenberg H et al. Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome. 1999 J. Clin. Endocrinol. Metab. pmid:10372729
Khan AR et al. Experience with norethisterone enanthate as injectable contraceptive. 1976 Bangladesh Med Res Counc Bull pmid:1037371
Sulak P et al. Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction. 1999 Contraception pmid:10382078
Mattsson LA et al. Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations. 1999 Obstet Gynecol pmid:10389719
Adamczyk M et al. O-(fluoresceinylmethyl)hydroxylamine (OFMHA): a reagent for the preparation of fluorescent O-(fluoresceinylmethyl)oxime (FMO)-steroid conjugates. 1999 Steroids pmid:10399885
Eriksen EF et al. Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women. 1999 J. Bone Miner. Res. pmid:10404024
Vestergaard P et al. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study. 1999 J. Clin. Endocrinol. Metab. pmid:10404791
Duncan AC et al. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. 1999 J. Clin. Endocrinol. Metab. pmid:10404811
Geisler J et al. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. 1999 J. Endocrinol. pmid:10425465
Paul AC and Choy CC Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. 1999 Br J Obstet Gynaecol pmid:10430209
van Hoof HJ et al. Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study. 1999 Clin. Endocrinol. (Oxf) pmid:10468912
Gravholt CH et al. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status. 1999 Clin. Endocrinol. (Oxf) pmid:10468952
Archer DF et al. Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group. 1999 Obstet Gynecol pmid:10472853
Rugarn O et al. Effects of estradiol, progesterone, and norethisterone on regional concentrations of galanin in the rat brain. 1999 Peptides pmid:10477130
Engmann L et al. Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study. 1999 Am. J. Obstet. Gynecol. pmid:10486466
Alexandersen P et al. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study. 1999 J. Clin. Endocrinol. Metab. pmid:10487657
Weisberg E et al. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol. 1999 Contraception pmid:10494484
Weisberg E et al. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring. 1999 Contraception pmid:10494485
Mendoza-Rodríguez CA et al. Variations of progesterone receptor and c-fos gene expression in the rat uterus after treatment with norethisterone and its A-ring reduced metabolites. 1999 Contraception pmid:10494488
Muneyyirci-Delale O and Karacan M Hormonal treatment of bilateral proximal tubal obstruction. 1999 Jun-Aug Int J Fertil Womens Med pmid:10499742
Archer DF et al. A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group. 1999 Obstet Gynecol pmid:10511348
Bjarnason K et al. Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. 1999 Maturitas pmid:10515673
el Nahal N et al. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion. 1999 Contraception pmid:10518231
Tran A et al. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. 1999 Am. J. Gastroenterol. pmid:10520843
Lewis-Barned NJ et al. Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women. 1999 J. Clin. Endocrinol. Metab. pmid:10522991
Collier TM et al. Mesenteric thrombosis associated with oral contraceptives. 1975 Jul-Aug Angiology pmid:1053592